During the corresponding time, Establishment Labs Holdings Inc recorded a revenue increase by 31.73 % year on year, sequentially revenue grew by 13.83 %. While revenue at the Establishment Labs Holdings Inc 's corporate clients
Establishment Labs Holdings Inc's Comment on Sales, Marketing and Customers
The company serves two primary customer segments: medical device distributors and direct sales to physicians, hospitals, and clinics. Its products are available in over 100 countries through exclusive distributors, except in the United States, Brazil, Argentina, and several European countries, where sales are conducted via a direct sales force. As of December 31, 2025, the sales organization comprised 278 employees and contractors. The company supports its sales personnel with marketing and training materials, mobile applications, and physician education events. It assists distributors in maintaining relationships with surgeons and clinics and positions its product as a premium offering with premium pricing. The company offers the Motiva Always Confident Warranty, which provides free replacement for ruptured Motiva Implants for the product's lifetime and replacement for implants affected by capsular contracture of Baker Grade III or IV severity within ten years post-implantation. Additional extended warranties are available for purchase, covering surgical costs related to rupture, capsular contracture, late forming seroma, double capsule complication, and BIA-ALCL. The company's marketing strategy includes social media, influencers, conferences, advertisements, and education.
News about Establishment Labs Holdings Inc Contracts
Establishment Labs Unveils Preserv in Brazil, Pioneering a New Era in Breast Aesthetics and Reconstruction Establishment Labs Holdings Inc. (NASDAQ: ESTA), a prominent player in the field of medical technology, continues to lead the charge in enhancing women s health and wellness, particularly in the realm of breast aesthetics and reconstruction. In a significant move, the company has announced the launch of its latest innovation, Preserv, in Brazil. This launch marks the first phase of a comprehensive global rollout, signaling a new chapter in the company s commitment to advancing minimally invasive solutions.As a global leader, Establishment Labs has consistently focused on improving the quality of life fo...
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a pioneering medical technology firm dedicated to enhancing women’s health and wellness, particularly in the realms of breast aesthetics and reconstruction, has recently published its 2024 Post Market Surveillance (PMS) Report. This announcement comes as the company moves into a significant growth phase, with broad shipping of its products across the United States now underway.Juan José Chacón-Quirós, the CEO and Founder of Establishment Labs, expressed his enthusiasm for the timing of the PMS report s publication. It is fitting that as we publish our 2024 PMS report, we begin broadly shipping across the United States,” he remarked, highlighting the str...
In a significant leap forward for breast aesthetics, Establishment Labs Holdings Inc. (NASDAQ: ESTA) has garnered approval from the U.S. Food and Drug Administration (FDA) for its innovative product line featuring Motiva SmoothSilk Ergonomix and Motiva SmoothSilk Round breast implants. This landmark decision represents not only a milestone for the company but also a transformative moment for women s health and wellness, particularly in the realms of breast augmentation and reconstruction.Establishment Labs, a leading global medical technology firm, is chiefly focused on enhancing the health and well-being of women through cutting-edge solutions in breast aesthetics. The approval encompasses both primary and ...
Revolutionizing Breast Aesthetics: Establishment Labs FDA Approval Marks a New Era for Women s Health In an invigorating shift for the world of breast aesthetics and reconstruction, Establishment Labs Holdings Inc. a trailblazer in medical technology, has secured the coveted approval from the U.S. Food and Drug Administration (FDA) for its innovative Motiva SmoothSilk Ergonomix and SmoothSilk Round breast implants. This landmark achievement heralds not just an evolution in surgical options but also a profound enhancement in the way women perceive their health, wellness, and self-image.For years, the conversation around breast augmentation has been predominantly dictated by conventional techniques and an oft...
Establishment Labs Holdings Inc’s Comment on Sales, Marketing and Customers
The company serves two primary customer segments: medical device distributors and direct sales to physicians, hospitals, and clinics. Its products are available in over 100 countries through exclusive distributors, except in the United States, Brazil, Argentina, and several European countries, where sales are conducted via a direct sales force. As of December 31, 2025, the sales organization comprised 278 employees and contractors. The company supports its sales personnel with marketing and training materials, mobile applications, and physician education events. It assists distributors in maintaining relationships with surgeons and clinics and positions its product as a premium offering with premium pricing. The company offers the Motiva Always Confident Warranty, which provides free replacement for ruptured Motiva Implants for the product's lifetime and replacement for implants affected by capsular contracture of Baker Grade III or IV severity within ten years post-implantation. Additional extended warranties are available for purchase, covering surgical costs related to rupture, capsular contracture, late forming seroma, double capsule complication, and BIA-ALCL. The company's marketing strategy includes social media, influencers, conferences, advertisements, and education.
Sources:
Establishment Labs Holdings Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Establishment Labs Holdings Inc’s corporate clients.
For your research, we’ve provided 9 tables on Establishment Labs Holdings Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
123.08 %